by Brian Cardillo | Nov 16, 2024 | News, Press Releases
WASHINGTON, D.C. NOVEMBER 15, 2024 – This afternoon, a third extension was officially posted to the Federal Register, granting the U.S. Drug Enforcement Administration (DEA) a clean, one-year extension of the remote prescribing of controlled substances. This critical...
by Allison Kavanagh | Nov 6, 2024 | News, Press Releases
WASHINGTON, D.C., NOVEMBER 6, 2024 – In response to today’s early morning results of the historic 2024 presidential election, with a majority of electoral college votes going to former President Donald Trump as its 47th president, the American Telemedicine...
by Allison Kavanagh | Sep 19, 2024 | News, Press Releases
WASHINGTON, DC, SEPTEMBER 18, 2024 – ATA Action, the American Telemedicine Association’s affiliated trade association focused on advocacy, today submitted a Statement for the Record to the U.S. House Energy and Commerce Committee, applauding their continued support of...
by Allison Kavanagh | Sep 12, 2024 | Press Releases
WASHINGTON, DC, SEPTEMBER 12, 2024 –ATA Action, the American Telemedicine Association’s affiliated trade association focused on advocacy, today announced the creation of the bipartisan ATA Action Political Action Committee (ATA Action PAC) to influence legislation...
by Allison Kavanagh | Sep 10, 2024 | Press Releases
WASHINGTON, D.C. September 10, 2024 – Today, more than 330 stakeholder organizations asked Congress and the White House to intervene to ensure ongoing access to remote prescribing of controlled substances. The letters were co-led by the American Telemedicine...
by Allison Kavanagh | Aug 28, 2024 | Press Releases
WASHINGTON, AUGUST 28, 2024 – The American Telemedicine Association (ATA) and ATA Action today submitted detailed comments to the Centers for Medicare and Medicaid Services (CMS) in response to the calendar year (CY) 2025 Physician Fee Schedule proposed rule. The ATA...